Terms: = Endocrine gland cancer AND KDSR, Q06136, 2531, ENSG00000119537, FVT1 AND Diagnosis
6 results:
1. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
[TBL] [Abstract] [Full Text] [Related]
2. Clinical significance of immunohistochemistry to detect BRAF V600E mutant protein in thyroid tissues.
Zhang Y; Liu L; Liu Y; Cao N; Wang L; Xing C
Medicine (Baltimore); 2021 Apr; 100(16):e25566. PubMed ID: 33879712
[TBL] [Abstract] [Full Text] [Related]
3. 1.0T MR-guided percutaneous coaxial cutting needle biopsy in pancreatic lesion diagnosis.
Liu C; Wang L; He X; Xu Y; Lu D; Li P; Lv R; Feng Y; Liu M; Li C
J Magn Reson Imaging; 2018 Aug; 48(2):382-388. PubMed ID: 29319916
[TBL] [Abstract] [Full Text] [Related]
4. Useful aspects of diagnosis of imprint cytology in intraoperative consultation of ovarian tumors: comparison between imprint cytology and frozen sections.
Azami S; Aoki Y; Iino M; Sakaguchi A; Ogura K; Ogishima D; Matsumoto T
Diagn Cytopathol; 2018 Jan; 46(1):28-34. PubMed ID: 29034605
[TBL] [Abstract] [Full Text] [Related]
5. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.
Massironi S; Conte D; Sciola V; Spampatti MP; Ciafardini C; Valenti L; Rossi RE; Peracchi M
Am J Gastroenterol; 2010 Sep; 105(9):2072-8. PubMed ID: 20372113
[TBL] [Abstract] [Full Text] [Related]
6. Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches.
Fideleff HL; Boquete HR; Sequera A; Suárez M; Sobrado P; Giaccio A
J Pediatr Endocrinol Metab; 2000 Mar; 13(3):261-7. PubMed ID: 10714751
[TBL] [Abstract] [Full Text] [Related]
